Clinical trial
From Nature to Bedside- Algae Based Bio Compound for Prevention and Treatment of Inflammation, Pain and IBD
NCT06227598 is registered in ClinicalTrials.gov with Federico II University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- From Nature to Bedside- Algae Based Bio Compound for Prevention and Treatment of Inflammation, Pain and IBD
- Lead sponsor
- Federico II University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- May 1, 2024
- Completion date
- September 1, 2026
- Enrollment
- 90 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
ibd